KPC Pharmaceuticals Inc (600422) — Cash Flow Reinvestment Rate
KPC Pharmaceuticals Inc (600422) has a Cash Flow Reinvestment Rate of 0.89x as of June 2025, reinvesting CN¥318.54 Million (capex CN¥13.08 Million plus investments CN¥-305.46 Million) from operating cash flow of CN¥358.28 Million. Explore 600422 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
KPC Pharmaceuticals Inc Cash Flow Reinvestment Rate (1999–2024)
Historical reinvestment intensity for KPC Pharmaceuticals Inc across 24 annual periods. Also explore KPC Pharmaceuticals Inc (600422) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for KPC Pharmaceuticals Inc (1999–2024)
Year-by-year capital reinvestment analysis for KPC Pharmaceuticals Inc. For live market cap and broader valuation context, see KPC Pharmaceuticals Inc (600422) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.30x | CN¥244.84 Million | CN¥808.07 Million | CN¥79.43 Million | ▼ -73.3% |
| 2023 | 1.14x | CN¥404.70 Million | CN¥356.08 Million | CN¥65.48 Million | ▼ -14.2% |
| 2022 | 1.32x | CN¥336.35 Million | CN¥253.90 Million | CN¥101.75 Million | ▼ -25.1% |
| 2021 | 1.77x | CN¥444.88 Million | CN¥251.63 Million | CN¥236.17 Million | ▲ +219.0% |
| 2020 | 0.55x | CN¥227.19 Million | CN¥409.94 Million | CN¥158.73 Million | ▼ -56.1% |
| 2019 | 1.26x | CN¥541.78 Million | CN¥429.50 Million | CN¥347.35 Million | ▼ -32.1% |
| 2018 | 1.86x | CN¥654.55 Million | CN¥352.07 Million | CN¥217.26 Million | ▲ +40.2% |
| 2017 | 1.33x | CN¥321.69 Million | CN¥242.53 Million | CN¥268.74 Million | ▲ +75.0% |
| 2016 | 0.76x | CN¥235.78 Million | CN¥311.16 Million | CN¥203.45 Million | ▼ -77.4% |
| 2015 | 3.35x | CN¥1.60 Billion | CN¥476.62 Million | CN¥210.82 Million | ▲ +469.8% |
| 2014 | 0.59x | CN¥222.98 Million | CN¥379.13 Million | CN¥222.98 Million | ▼ -33.1% |
| 2013 | 0.88x | CN¥212.65 Million | CN¥241.97 Million | CN¥212.65 Million | ▲ +52.2% |
| 2012 | 0.58x | CN¥123.22 Million | CN¥213.33 Million | CN¥123.22 Million | ▲ +89.0% |
| 2011 | 0.31x | CN¥42.85 Million | CN¥140.24 Million | CN¥42.85 Million | ▼ -56.7% |
| 2010 | 0.71x | CN¥64.16 Million | CN¥90.82 Million | CN¥64.16 Million | ▲ +382.6% |
| 2009 | 0.15x | CN¥18.82 Million | CN¥128.57 Million | CN¥18.82 Million | ▲ +2.4% |
| 2008 | 0.14x | CN¥13.09 Million | CN¥91.59 Million | CN¥13.09 Million | ▲ +11.5% |
| 2007 | 0.13x | CN¥16.67 Million | CN¥130.06 Million | CN¥16.67 Million | ▼ -73.0% |
| 2006 | 0.47x | CN¥29.03 Million | CN¥61.25 Million | CN¥29.03 Million | ▼ -9.5% |
| 2003 | 0.52x | CN¥32.08 Million | CN¥61.23 Million | CN¥32.08 Million | ▼ -88.6% |
| 2002 | 4.58x | CN¥79.62 Million | CN¥17.38 Million | CN¥79.62 Million | ▲ +1594.6% |
| 2001 | 0.27x | CN¥18.13 Million | CN¥67.07 Million | CN¥18.13 Million | ▼ -46.7% |
| 2000 | 0.51x | CN¥24.20 Million | CN¥47.76 Million | CN¥24.20 Million | ▲ +141.1% |
| 1999 | 0.21x | CN¥12.67 Million | CN¥60.24 Million | CN¥12.67 Million | — |